Statistics for Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial.

Total visits

views
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial. 154

Total visits per month

views
December 2023 0
January 2024 0
February 2024 0
March 2024 0
April 2024 0
May 2024 0
June 2024 0

File Visits

views
Lancet Publication.pdf 1744

Top country views

views
Germany 32
United States 21
United Kingdom 18
China 5
South Korea 4
Singapore 3
France 1
Morocco 1

Top city views

views
Kiez 14
Alexandria 6
Guangzhou 5
Changi 2
Seocho 2
Seoul 2
Woodbridge 2
Boardman 1
Brooklyn 1
Carson City 1
Houston 1
Las Vegas 1
Mountain View 1
Taylorsville 1
Wilmington 1
Yulee 1